Jubilant Pharmova board to meet for Q2, half-year results

Jubilant Pharmova Limited announced that its board of directors will meet on Friday, October 31, 2025. The meeting's primary purpose is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year period ended September 30, 2025.

The announcement was made on October 14, 2025, to both the BSE Limited and the National Stock Exchange of India Limited. This intimation complies with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Further details regarding the board meeting and its outcomes will be simultaneously posted on the company's website.